Showing 1 - 8 results of 8 for search 'M. J. Kersten', query time: 0.03s
Refine Results
-
1
P1254: RESPONSE TO DA-EPOCH-R IN PATIENTS WITH HIGH GRADE B CELL LYMPHOMA IS ASSOCIATED WITH A REDUCTION OF PD1 POSITIVE EXHAUSTED CD8 T CELLS by V. de Jonge, C. Duetz, W. Bruins, E. van Werkhoven, M. Nijland, K. de Heer, M. van der Poel, Y. Sandberg, C. Klerk, D. de Jong, J. Zijlstra, M. J. Kersten, T. Mutis, M. Chamuleau
Published 2022-06-01
Article -
2
PB2115: TRIAL IN PROGRESS: A RANDOMIZED PHASE II STUDY OF MB-CART2019.1 COMPARED TO STANDARD OF CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR AUTOLOGOUS ST... by P. Borchmann, P. Vandenberghe, A. Urbano, C. Haioun, F. Lemonnier, L. Griškevicius, S. Maury, S. Holtkamp, B. Friedrichs, G. Zadoyan, L. Hanssens, C. Brillant, U. Bethke, M. Assenmacher, I. Bürger, B. Philippe, T. Overstijns, U. Jäger, M. J. Kersten
Published 2022-06-01
Article -
3
P1530: PERITRANFUSIONAL C1-INHIBITOR IN PATIENTS WITH SEVERE COMPLEMENT-MEDIATED AUTOIMMUNE HEMOLYTIC ANEMIA: AN OPEN LABEL PHASE 2 TRIAL. by E. C. W. de Boer, M. Jalink, L. Delvasto-Nuñes, E. M. Meulenbroek, I. Baas, S. R. Janssen, E. E. Dijkman, K. A. Gelderman, D. Wouters, M. D. Engel, M. de Haas, M.-J. Kersten, I. Jongerius, S. Zeerleder, J. M. Vos
Published 2022-06-01
Article -
4
P1462: POPULATION-BASED REAL WORLD RESULTS OF CD19-DIRECTED CAR T-CELL THERAPY FOR PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA: A DUTCH CAR T-CELL TUMORBOARD EXPERIE... by A. M. Spanjaart, E. Pennings, P. Mutsaers, S. van Dorp, M. Jak, J. van Doesem, J. de Boer, J. Vermaat, A. Sijs-Szabo, M. van der Poel, I. Kuipers, M. Chamuleau, I. Nijhof, M. Minnema, P. Lugtenburg, T. van Meerten, M. J. Kersten
Published 2022-06-01
Article -
5
P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STUDY INCLUDING 2-YEAR RITUXIMAB MAINTENANCE AFTER INDUCTION WITH IXAZOMIB, RITUXIMAB AND DEXAMETHASONE IN RELAPSED WALDENST... by M.-A. Dimopoulos, K. Amaador, M. C. Minnema, K. Nasserinejad, M. Kap, E. Kastritis, M. Gavriatopoulou, W. Kraan, M. E. D. Chamuleau, D. Deeren, L. Tick, J. K. Doorduijn, F. Offner, L. H. Böhmer, R. D. Liu, S. T. Pals, J. M. Vos, M. J. Kersten
Published 2022-06-01
Article -
6
P1209: INCIDENCE, TREATMENT AND OUTCOME OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA: A POPULATION-BASED COHORT STUDY IN THE NETHERLANDS by F. O. Meeuwes, M. Brink, M. W. Van der Poel, M. J. Kersten, M. J. Wondergem, P. G. Mutsaers, L. H. Böhmer, F. J. S. H. Woei-A-Jin, O. Visser, R. Oostvogels, P. M. Jansen, W. J. Plattel, G. A. Huls, J. S. Vermaat, M. Nijland
Published 2022-06-01
Article -
7
P1117: THREE-YEAR FOLLOW-UP OF OUTCOMES WITH KTE-X19 IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN ZUMA-2 by M. L. Wang, J. Munoz, A. Goy, F. L. Locke, C. A. Jacobson, B. T. Hill, J. M. Timmerman, H. Holmes, I. W. Flinn, D. B. Miklos, J. M. Pagel, M. J. Kersten, R. Houot, A. Beitinjaneh, W. Peng, X. Fang, R. R. Shen, R. Siddiqi, I. Kloos, P. M. Reagan
Published 2022-06-01
Article -
8
S211: CLINICAL AND PATIENT-REPORTED OUTCOMES IN A PHASE 3 STUDY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) VS STANDARD-OF-CARE IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL L... by A. Sureda, J. Westin, F. L. Locke, M. Dickinson, A. Ghobadi, M. Elsawy, T. van Meerten, D. B. Miklos, M. Ulrickson, M.-A. Perales, U. Farooq, L. Wannesson, L. Leslie, M. J. Kersten, C. A. Jacobson, J. M. Pagel, G. Wulf, P. Johnston, A. P. Rapoport, L. I. Gordon, Y. Yang, A. Peng, L. Du, J. T. Snider, J. Shah, M. Schupp, P. Cheng, C. To, O. O. Oluwole
Published 2022-06-01
Article